TNFSF10 and experimental autoimmune encephalomyelitis: Similar findings were also observed in mice with experimental autoimmune encephalomyelitis (EAE).9 Recent studies further demonstrated that administration of TRAIL is effective in suppressing autoimmune inflammation via an apoptosis-independent pathway.10,11 All these results imply a novel immunoregulatory role of TRAIL in autoimmune diseases.